London - University College London

ECMC London UCL

University College London (UCL) ECMC aims to develop new cancer therapies and undertake early phase clinical trials that are fully informed by modern molecular and imaging technologies. There is particular expertise and dedicated facilities for trials of antibody-targeted, radiation, photodynamic and vascular therapies and biomedical informatics.

Research Areas

Focus

Immunotherapy, bioinformatics, imaging

Disease Area

Basic research, relevant to most types of cancer

 

Goals

Goals

For further information on the goals and objectives of UCL ECMC go to:

More about Goals

 

Skills

Skills

UCL ECMC principal investigators and staff have a diverse range of skills and expertise.

More about Skills

 

Facilities

Facilities

UCL ECMC has access to a range of research facilities that are utilised in studies.

More about Facilities

 

Achievements

Achievements

To learn more about the scientific and operational achievements of UCL ECMC go to:

More Achievements

 

Centre Leads

Professor Richard Begent and Professor John Hartley
c/o Carmel Hopkins (PA to Professor Begent)
UCL Cancer Institute
Paul O'Gorman Building
University College London
72 Huntley Street
London
WC1E 6BT
Tel: +44 (0) 20 7472 6151
Fax: +44 (0) 20 7794 3341

 

Other key personnel

Senior Clinical Trial Administrator and Research Governance Manager

Sawretse Leslie
Tel: +44(0) 20 7679 0785
Fax: +44(0) 20 7679 0783

Early Phase Lead Research Nurse

Kerry Guile

Data Manager

Alan Sahin

 

Clinical Trials Enquiries

You can also find out about trials recruiting in London on the CancerHelp UK clinical trials database.